What does Selecta Biosciences, Inc. do?

Jun 22 2025 06:20 PM IST
share
Share Via
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted immune-modulating therapies for rare diseases. As of March 2025, it reported net sales of $1 million and a net loss of $18 million, with a market cap of $251.85 million.
Overview:
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company in the Pharmaceuticals & Biotechnology industry, focusing on developing targeted therapies to modulate the immune system for rare and serious diseases. Financial Snapshot: Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -18 Million (Quarterly Results - Mar 2025) Market cap: USD 251.85 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 8.11 Return on Equity: 158.25% Price to Book: -11.56 Contact Details: Address: 65 Grove Street, WATERTOWN MA: 02472-2891 Tel: ['1 617 9231400', '1 646 378-2922'] Fax: 1 617 9243454 Website: http://selectabio.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Selecta Biosciences, Inc. overvalued or undervalued?
Sep 20 2025 05:59 PM IST
share
Share Via
Is Selecta Biosciences, Inc. overvalued or undervalued?
Jun 25 2025 08:34 AM IST
share
Share Via
How big is Selecta Biosciences, Inc.?
Jun 22 2025 05:45 PM IST
share
Share Via